An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...

Researchers are enhancing immunotherapy effects against malignant tumors by developing and validating patent-ending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine ...

Researchers at Ludwig Maximilian University of Munich developed hybrid PLGA-PBAE nanoparticles that delivered mRNA vaccines ...

A new nanoparticle made from the medical polymer PLGA and the blood protein albumin can carry higher doses of drugs and remain stable longer, offering improved delivery and fewer side effects. For ...

Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.

Active pharmaceutical ingredients (APIs), including both small molecules and biologic compounds, are often encapsulated in microspheres and nanoparticles. This encapsulation is utilized for specific ...

When designing a nanoparticle-enabled drug delivery system, many intersecting considerations must be taken into account, such as the target location of the drug payload, the method of delivery, uptake ...

Scientists at Xi’an Jiaotong-Liverpool University (XJTLU) and at Nanjing University have combined a widely used medical polymer with a natural blood protein to develop a new nanoparticle drug delivery ...

A new nanoparticle capable of carrying much higher doses of drugs while staying stable for extended periods could make treatments more effective. A new nanoparticle made from the medical polymer PLGA ...